EPTIFIBATIDE INDUCED PROFOUND THROMBOCYTOPENIA: A NEW APPROACH TO MANAGEMENT USING INTRAVENOUS IMMUNOGLOBULIN AND HIGH DOSE STEROIDS
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)32845-1
Abstract: Eptifibatide (Ep) induced profound thrombocytopenia (TP) has been rarely described. We report a case of acute profound TP after intravenous (IV) Ep. A 59 year old man with history of coronary artery disease and two… read more here.
Keywords: eptifibatide induced; new approach; thrombocytopenia new; profound thrombocytopenia ... See more keywords
Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011997
Abstract: Rationale: Thrombocytopenia caused by linezolid (LZD) is common, with a reported prevalence as high as 11.8%. Platelets typically reach normal levels 7 days after LZD withdrawal. However, recurrent profound thrombocytopenia due to LZD usage and… read more here.
Keywords: thrombocytopenia; recurrent profound; profound thrombocytopenia; thrombocytopenia due ... See more keywords